Enhancement of anti-cancer activity of cytotoxic chemotherapy with protection of normal tissues by inhibition of P.G. synthesis.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000188:drug therapy / Q000532:radiotherapy; D004357:Drug Synergism; D051379:Mice; D008808:Mice, Inbred CBA; D011448:Prostaglandin Antagonists / Q000627:therapeutic use*; D013997:Time Factors
D000970:Antineoplastic Agents; D011448:Prostaglandin Antagonists